These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22764578)
1. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs. Neuhaus W; Mandikova J; Pawlowitsch R; Linz B; Bennani-Baiti B; Lauer R; Lachmann B; Noe CR Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein. Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564 [TBL] [Abstract][Full Text] [Related]
4. A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2. Neuhaus W; Lauer R; Oelzant S; Fringeli UP; Ecker GF; Noe CR J Biotechnol; 2006 Aug; 125(1):127-41. PubMed ID: 16730091 [TBL] [Abstract][Full Text] [Related]
5. Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation. Fang W; Lv P; Geng X; Shang E; Yang Q; Sha L; Li Y Neurochem Int; 2013 Jan; 62(1):23-30. PubMed ID: 23142723 [TBL] [Abstract][Full Text] [Related]
6. An in vitro transport model for rapid screening and predicting the permeability of candidate compounds at blood-brain barrier. Yang ZH; Sun X; Mei C; Sun XB; Liu XD; Chang Q J Asian Nat Prod Res; 2011 Dec; 13(12):1087-97. PubMed ID: 22115032 [TBL] [Abstract][Full Text] [Related]
7. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123. Tai LM; Reddy PS; Lopez-Ramirez MA; Davies HA; Male DK; Loughlin AJ; Romero IA Brain Res; 2009 Oct; 1292():14-24. PubMed ID: 19631619 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein. Obradovic T; Dobson GG; Shingaki T; Kungu T; Hidalgo IJ Pharm Res; 2007 Feb; 24(2):318-27. PubMed ID: 17180728 [TBL] [Abstract][Full Text] [Related]
9. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. Chikhale EG; Burton PS; Borchardt RT J Pharmacol Exp Ther; 1995 Apr; 273(1):298-303. PubMed ID: 7714780 [TBL] [Abstract][Full Text] [Related]
10. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier. Hsiao P; Bui T; Ho RJ; Unadkat JD Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117 [TBL] [Abstract][Full Text] [Related]
11. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin. Zong J; Pollack GM J Pharmacol Exp Ther; 2003 Aug; 306(2):556-62. PubMed ID: 12721332 [TBL] [Abstract][Full Text] [Related]
12. Influence of P-glycoprotein on brucine transport at the in vitro blood-brain barrier. Xu DH; Yan M; Li HD; Fang PF; Liu YW Eur J Pharmacol; 2012 Sep; 690(1-3):68-76. PubMed ID: 22749978 [TBL] [Abstract][Full Text] [Related]
13. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data. Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090 [TBL] [Abstract][Full Text] [Related]
14. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869 [TBL] [Abstract][Full Text] [Related]
15. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in in vitro cell experiments. Yang ZH; Sun X; Qi Y; Mei C; Sun XB; Du GH J Asian Nat Prod Res; 2012; 14(1):14-21. PubMed ID: 22263589 [TBL] [Abstract][Full Text] [Related]
16. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Zhang C; Kwan P; Zuo Z; Baum L Life Sci; 2010 Jun; 86(23-24):899-905. PubMed ID: 20417647 [TBL] [Abstract][Full Text] [Related]
17. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Bachmeier CJ; Trickler WJ; Miller DW Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372 [TBL] [Abstract][Full Text] [Related]
18. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372 [TBL] [Abstract][Full Text] [Related]
19. Transport of amentoflavone across the blood-brain barrier in vitro. Gutmann H; Bruggisser R; Schaffner W; Bogman K; Botomino A; Drewe J Planta Med; 2002 Sep; 68(9):804-7. PubMed ID: 12357391 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier. He L; Zhao C; Yan M; Zhang LY; Xia YZ Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]